NEW YORK (GenomeWeb News) - High Throughput Genomics said today it will collaborate with the University of California, San Diego, to generate arrays from mouse tissue samples and from cell lysates to evaluate genes tied to inflammation and insulin production.
Under the agreement, HTG will work with the UCSD Department of Medicine's Division of Endocrinology and Metabolism to study how insulin resistance and inflammation function in diabetes.
The agreement also calls for HTG to provide its ArrayPlate lysis-only quantitative Nuclease Protection Assay technology, or qNPA, platform, which the company said allows researchers to test any sample, including fixed tissues, without extraction or target amplification.